SOSV

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

CroBio Ltd is an agricultural biotechnology company based in Macclesfield, United Kingdom, founded in 2019 by experts in microbiology and engineering. The company focuses on developing environmentally sustainable solutions to combat global agricultural drought. Its technology leverages genetically engineered root-associated bacteria that produce a sponge-like biomaterial, facilitating biologically active water retention in soil. This innovative approach aims to improve soil health and enhance water management in agricultural practices.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Machine Medicine Technologies Ltd is a healthcare company that develops an artificial intelligence platform designed to assess motor characteristics in Parkinson's disease patients using video clips. Its flagship product, KELVIN-PD, employs computer vision and pose estimation techniques to objectively track patient movements, capturing key metrics related to symptoms such as tremors and bradykinesia. This platform facilitates the secure storage and management of patient data and is accessible from any device, making it both affordable and user-friendly. Established in 2017 and headquartered in London, the company aims to enhance the understanding of the brain and advance neuro-therapeutics by providing interpretable tools for behavioral measurement.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

ChronosDx is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics. The firm focuses on creating bioassay technology tailored for diagnostics, drug screening, and development. ChronosDx develops high-performance, cost-effective, and scalable technology that effectively detects various biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This innovative platform enables medical professionals to monitor biomarkers both in-line and in vivo, enhancing the capabilities of healthcare diagnostics.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

Samphire Neuroscience provides solutions that specialize in women's health. The company was founded in 2021 and is based in London, England.

Reach Industries, founded in 2020 and headquartered in Bristol, UK, is a software development company that specializes in creating advanced products for laboratories. The company develops a platform aimed at enhancing productivity and quality in lab environments. Its robotics software supports scientists by improving laboratory efficiency through features such as predictive quality and maintenance analytics, asset condition monitoring, and process optimization. This innovative approach enables clients to effectively manage material flow and securely store telematics and sensor data in the cloud.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Coffee Exchange operates a global digital marketplace that aims to transform the green coffee trading industry by facilitating direct transactions between coffee producers and roasters. The platform provides stakeholders with transparent, real-time information, enabling informed buying and selling decisions. By eliminating intermediaries, Coffee Exchange offers commercial and logistics support, resulting in cost savings of 10-15% and significantly increasing revenue for producers, who can earn 100-150% more. The platform streamlines the coffee trading process through services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. Currently, over 1,100 coffee roasters in China are actively engaged with select producers from countries like Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. Coffee Exchange is also testing its platform in the USA, with plans to expand into the UK and South Korea.

Kyomei is a company based in Oxford, England, founded in 2021, that focuses on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Utilizing innovative plant cell biology, Kyomei employs a unique method to scale the production of myoglobin in plants, which enhances the umami flavor of meat alternatives. This approach not only improves the taste of plant-based products but also supports efforts to reduce carbon emissions associated with traditional animal farming. Through its sustainable practices, Kyomei aims to provide consumers with flavorful plant-based meat options while contributing to a more environmentally friendly food system.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Kutanios is a biotechnology company based in London that specializes in the development of innovative compounds for various skincare applications, including anti-aging, sun protection, and anti-acne treatments. The firm focuses on creating biodegradable molecules that utilize a novel mechanism of action, which targets lipid peroxides generated by environmental factors such as sunlight, pollution, and tobacco smoke. By employing green technology in the manufacturing process, Kutanios aims to provide effective solutions that help prevent skin aging, sunburn, and skin cancers, catering to the needs of consumers seeking safer and more effective skincare options.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Caura Ltd. is a London-based company established in 2018 that specializes in vehicle management solutions. The company offers a platform that enables drivers to efficiently handle various aspects of car ownership, including payments for parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Additionally, Caura provides a product called Caura Protect, which allows users to purchase and manage motor insurance through a network of insurers. The company also focuses on developing microelectronic devices that monitor health metrics such as lactate and glucose levels, along with heart-rate and accelerometry data. Furthermore, Caura creates application software that connects to these devices to generate reports and analyze the collected data.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

SunGreenH2 is a company focused on producing green hydrogen through advanced nanotechnology and proprietary electrolysis systems. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables efficient on-site hydrogen production using only sunlight and water. This innovative approach results in zero emissions and significantly reduces costs, facilitating the widespread adoption of green hydrogen across various sectors, including transportation, energy storage, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to unlock sustainable and scalable hydrogen solutions for industries worldwide.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, specializing in the development of plant-based proteins for the food and beverage industries. Established in 2018, the company focuses on creating innovative protein sweeteners, including brazzein, utilizing its proprietary protein engineering and expression platforms. These novel protein-based molecules are designed to offer non-calorific alternatives that address sugar content and associated health concerns. By providing advanced solutions for the food, health, and nutrition sectors, Magellan Life Sciences aims to meet the growing demand for healthier ingredients in consumer products.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Arthronica Ltd is a London-based company that specializes in developing an artificial intelligence platform for patient monitoring and rehabilitation, particularly focused on chronic rheumatic conditions such as arthritis. Established in 2018, the company utilizes advanced technologies, including skeletal tracking, visual strength assessments, image analysis, and video analysis, to create solutions that assist medical practitioners in monitoring and predicting disease activities. Arthronica's innovative system incorporates force-sensing vision and 3D CAD modeling to measure swelling, thereby providing critical insights into disease progression. The company is actively engaged in clinical trials in both the United Kingdom and the United States to further validate its technology and enhance patient care. Additionally, Arthronica has participated in the Entrepreneur First program, which supports individuals in building technology companies.

Brightcure is solving the lack of treatment options available for patients suffering from recurrent urinary tract infections (UTIs). UTIs are one of world’s most common infections, affecting 50% of women and 12% of men worldwide. Current UTI treatments are not effective, can cause serious side effects, and often accelerate antibiotic-resistant infections. Total UTI costs currently amount over $ 8.6B per year. With UTI bacteria becoming increasingly difficult to treat, the size of the UTI market is expected to reach $ 12.41B by 2025. Brightcure utilizes the natural microbiome to reduce harmful bacteria and replenish the good bacteria in the vaginal flora. Brightcure’s bioactive intimate cream boosts the natural immune system to promote a healthy urinary tract. BrightCure was founded in 2019 and is headquartered in London, England. In 2020, BrightCure got a seed investment from SOSV and was selected as 1 out of 9 companies to be part of the world's largest biotech accelerator, Indiebio, to develop its first product. BrightCure has been selected as one of the Top 7 companies of the McKinsey Venture Challenge, Top 5 of the Mayor of London Competition, has won Imperial College's White City Innovation Program, and has taken part in the finals of ‘The Pitch’ London Competition being selected among 850 other applications.

Brightcure is solving the lack of treatment options available for patients suffering from recurrent urinary tract infections (UTIs). UTIs are one of world’s most common infections, affecting 50% of women and 12% of men worldwide. Current UTI treatments are not effective, can cause serious side effects, and often accelerate antibiotic-resistant infections. Total UTI costs currently amount over $ 8.6B per year. With UTI bacteria becoming increasingly difficult to treat, the size of the UTI market is expected to reach $ 12.41B by 2025. Brightcure utilizes the natural microbiome to reduce harmful bacteria and replenish the good bacteria in the vaginal flora. Brightcure’s bioactive intimate cream boosts the natural immune system to promote a healthy urinary tract. BrightCure was founded in 2019 and is headquartered in London, England. In 2020, BrightCure got a seed investment from SOSV and was selected as 1 out of 9 companies to be part of the world's largest biotech accelerator, Indiebio, to develop its first product. BrightCure has been selected as one of the Top 7 companies of the McKinsey Venture Challenge, Top 5 of the Mayor of London Competition, has won Imperial College's White City Innovation Program, and has taken part in the finals of ‘The Pitch’ London Competition being selected among 850 other applications.

Machine Medicine Technologies Ltd is a healthcare company that develops an artificial intelligence platform designed to assess motor characteristics in Parkinson's disease patients using video clips. Its flagship product, KELVIN-PD, employs computer vision and pose estimation techniques to objectively track patient movements, capturing key metrics related to symptoms such as tremors and bradykinesia. This platform facilitates the secure storage and management of patient data and is accessible from any device, making it both affordable and user-friendly. Established in 2017 and headquartered in London, the company aims to enhance the understanding of the brain and advance neuro-therapeutics by providing interpretable tools for behavioral measurement.

Multus is a London-based company established in 2019 that specializes in providing affordable and efficient growth media for the cultivated meat industry. By employing a machine learning approach, Multus develops entirely animal-free growth media tailored specifically for animal cells, helping cultivated meat companies scale their production while maintaining high performance. The company focuses on optimizing growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the environmental drawbacks associated with traditional animal serum-based media. This innovative solution supports the growth of diverse animal cell types and tissues, enabling clients to produce sustainable meat products while minimizing the environmental and economic impacts of conventional meat production.

Pear Bio is a biotechnology company based in Boston and London that focuses on developing precision medicine therapeutics for challenging cancer cases. By analyzing tumor biopsies and blood samples from patients, the company utilizes multi-omics approaches to identify new therapeutic targets. Their proprietary immune-microtumor system allows them to test the effectiveness of drug candidates directly on patient tumor samples. Pear Bio's innovative technology includes a specialized hydrogel that cultivates tumors outside the human body, effectively simulating drug resistance and streamlining the treatment selection process. This enables the identification of the most effective therapies for individual patients, thereby reducing the reliance on trial-and-error methods in cancer treatment.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Breather is an app and a provider of space-as-a-service, with a growing network of private workspaces built for productivity. It enables businesses to access flexible workspace by the hour, day, or month. Every space is designed to be comfortable, private, and productive, with plug-and-play technology that ensures that can get to work as soon as the arrival. Founded by CEO Julien Smith in 2012, the company has grown to include hundreds of locations in 10 major across the globe including New York, San Francisco, Los Angeles, and London.

Bubbleye is an innovative AI startup specializing in mobile marketing solutions. With research and development headquarters in Taipei, the company addresses inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye leverages its global talent pool to deliver cutting-edge technology to clients, which include leading game publishers from the Americas, Europe, and Asia. The company's recent Series A funding round was supported by Taipei-based Darwin Ventures and notable angel investors, enhancing its growth trajectory. Bubbleye's culture encourages innovation and collaboration, driven by a shared passion for disrupting the mobile marketing landscape and delivering superior performance for its clients.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Arthronica Ltd is a London-based company that specializes in developing an artificial intelligence platform for patient monitoring and rehabilitation, particularly focused on chronic rheumatic conditions such as arthritis. Established in 2018, the company utilizes advanced technologies, including skeletal tracking, visual strength assessments, image analysis, and video analysis, to create solutions that assist medical practitioners in monitoring and predicting disease activities. Arthronica's innovative system incorporates force-sensing vision and 3D CAD modeling to measure swelling, thereby providing critical insights into disease progression. The company is actively engaged in clinical trials in both the United Kingdom and the United States to further validate its technology and enhance patient care. Additionally, Arthronica has participated in the Entrepreneur First program, which supports individuals in building technology companies.

Rize is a virtual marketplace for clinical trials. It is a patient management platform used to reinvent how patients and researchers interact. The company's patient-centric platform matches people with the appropriate clinical trial and offers the ability to participate digitally. Rize Health was founded in 2019 and is headquartered in London, Ontario.

Coffee Exchange operates a global digital marketplace that aims to transform the green coffee trading industry by facilitating direct transactions between coffee producers and roasters. The platform provides stakeholders with transparent, real-time information, enabling informed buying and selling decisions. By eliminating intermediaries, Coffee Exchange offers commercial and logistics support, resulting in cost savings of 10-15% and significantly increasing revenue for producers, who can earn 100-150% more. The platform streamlines the coffee trading process through services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. Currently, over 1,100 coffee roasters in China are actively engaged with select producers from countries like Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. Coffee Exchange is also testing its platform in the USA, with plans to expand into the UK and South Korea.

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Bubbleye is an innovative AI startup specializing in mobile marketing solutions. With research and development headquarters in Taipei, the company addresses inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye leverages its global talent pool to deliver cutting-edge technology to clients, which include leading game publishers from the Americas, Europe, and Asia. The company's recent Series A funding round was supported by Taipei-based Darwin Ventures and notable angel investors, enhancing its growth trajectory. Bubbleye's culture encourages innovation and collaboration, driven by a shared passion for disrupting the mobile marketing landscape and delivering superior performance for its clients.

Machine Medicine Technologies Ltd is a healthcare company that develops an artificial intelligence platform designed to assess motor characteristics in Parkinson's disease patients using video clips. Its flagship product, KELVIN-PD, employs computer vision and pose estimation techniques to objectively track patient movements, capturing key metrics related to symptoms such as tremors and bradykinesia. This platform facilitates the secure storage and management of patient data and is accessible from any device, making it both affordable and user-friendly. Established in 2017 and headquartered in London, the company aims to enhance the understanding of the brain and advance neuro-therapeutics by providing interpretable tools for behavioral measurement.

Chronomics Ltd is a tech-bio company based in Norwich, United Kingdom, founded in 2017. It specializes in manufacturing testing kits and developing an artificial intelligence platform for DNA methylation analysis. The company provides insights into biological age, smoke exposure, metabolic state, health risks, eye color, and hereditary intolerance. Chronomics aims to make biological information more accessible and actionable, addressing the complexities and costs associated with obtaining such data. By creating bio-infrastructure across various sectors, the company enhances the use of biomarkers to inform everyday decisions in areas such as telehealth, travel, and wellness. Through partnerships with major organizations, Chronomics seeks to transform the way biological information is utilized for diagnosis, personalization, and evaluation of health-related offerings.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Coffee Exchange operates a global digital marketplace that aims to transform the green coffee trading industry by facilitating direct transactions between coffee producers and roasters. The platform provides stakeholders with transparent, real-time information, enabling informed buying and selling decisions. By eliminating intermediaries, Coffee Exchange offers commercial and logistics support, resulting in cost savings of 10-15% and significantly increasing revenue for producers, who can earn 100-150% more. The platform streamlines the coffee trading process through services such as coffee evaluation, logistics, customs clearance, quality inspections, and marketing support. Currently, over 1,100 coffee roasters in China are actively engaged with select producers from countries like Ethiopia, Rwanda, Ecuador, Colombia, Guatemala, and El Salvador. Coffee Exchange is also testing its platform in the USA, with plans to expand into the UK and South Korea.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to extend the life expectancy of glioblastoma patients, a group historically faced with limited treatment options and poor survival rates. Recognizing the urgent need for effective therapies, co-founders Dr. Richard Fu and Dr. Chris Bullock created a solution to address both the clinical and quality of life challenges faced by patients. The company has garnered nearly $1 million in funding from UK institutions, including Innovate UK, and over $1 million in equity funding from international life science investors. With a multidisciplinary team based in Alderley Park, Cheshire, QV Bioelectronics is dedicated to advancing GRACE from research to clinical application, utilizing cutting-edge materials science to enhance treatment outcomes for patients.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Encelo Laboratories Limited, founded in 2017 and based in London, develops innovative cell isolation tools that provide researchers with non-invasive, on-demand, and remote access to individual cells. Its flagship product, the Cell Isolation Cup, enables the selective isolation of live cells from urine, preserving them for shipment. The company's technology aims to enhance personalized medicine by facilitating universal access to stem cells and making stem cell treatments more cost-effective. Encelo's solutions serve a diverse clientele, including pharmaceutical companies, academic researchers, biobanks, and clinicians, supporting advancements in stem cell research, cell separation, and cell sequencing. By offering unprecedented access to human cells, the company aims to empower researchers and improve outcomes in personalized medicine.

Chronomics Ltd is a tech-bio company based in Norwich, United Kingdom, founded in 2017. It specializes in manufacturing testing kits and developing an artificial intelligence platform for DNA methylation analysis. The company provides insights into biological age, smoke exposure, metabolic state, health risks, eye color, and hereditary intolerance. Chronomics aims to make biological information more accessible and actionable, addressing the complexities and costs associated with obtaining such data. By creating bio-infrastructure across various sectors, the company enhances the use of biomarkers to inform everyday decisions in areas such as telehealth, travel, and wellness. Through partnerships with major organizations, Chronomics seeks to transform the way biological information is utilized for diagnosis, personalization, and evaluation of health-related offerings.

Caura Ltd. is a London-based company established in 2018 that specializes in vehicle management solutions. The company offers a platform that enables drivers to efficiently handle various aspects of car ownership, including payments for parking, tolls, congestion charges, MOTs, vehicle tax, and insurance. Additionally, Caura provides a product called Caura Protect, which allows users to purchase and manage motor insurance through a network of insurers. The company also focuses on developing microelectronic devices that monitor health metrics such as lactate and glucose levels, along with heart-rate and accelerometry data. Furthermore, Caura creates application software that connects to these devices to generate reports and analyze the collected data.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, specializing in the development of plant-based proteins for the food and beverage industries. Established in 2018, the company focuses on creating innovative protein sweeteners, including brazzein, utilizing its proprietary protein engineering and expression platforms. These novel protein-based molecules are designed to offer non-calorific alternatives that address sugar content and associated health concerns. By providing advanced solutions for the food, health, and nutrition sectors, Magellan Life Sciences aims to meet the growing demand for healthier ingredients in consumer products.

Kokoon Technology Limited is a digital health company based in London, United Kingdom, specializing in sleep enhancement solutions. Founded in 2013, the company manufactures sleep sensing headphones that incorporate EEG brainwave sensing technology to monitor sleep patterns. These headphones feature active noise cancellation, noise isolation, and white noise capabilities for improved sleep quality. Additionally, Kokoon offers a mobile application that includes an audio relaxation library and sleep analysis tools, utilizing movement and EEG sensors to gain insights into individual sleep behaviors. By combining advances in sensor technology and data science, Kokoon aims to personalize and enhance the sleep experience for users.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at providing clean air for individuals in polluted megacities such as Beijing and London. The company utilizes patented air purifying technology, which has been independently validated to be significantly more effective than traditional masks, filtering out dust and smoke particles through an active nanofiltration system. This innovative approach allows users to commute and exercise without the risks associated with pollution, promoting respiratory health while ensuring comfort and style. Aō Air's mission focuses on empowering urban residents to reclaim their environment and breathe clean air amidst increasing urban pollution challenges.

Kokoon Technology Limited is a digital health company based in London, United Kingdom, specializing in sleep enhancement solutions. Founded in 2013, the company manufactures sleep sensing headphones that incorporate EEG brainwave sensing technology to monitor sleep patterns. These headphones feature active noise cancellation, noise isolation, and white noise capabilities for improved sleep quality. Additionally, Kokoon offers a mobile application that includes an audio relaxation library and sleep analysis tools, utilizing movement and EEG sensors to gain insights into individual sleep behaviors. By combining advances in sensor technology and data science, Kokoon aims to personalize and enhance the sleep experience for users.

Aptapp specialises in creating solutions that add Mobility to Commerce. Their experts and solutions help stimulate growth, maximise returns, and ensure long term sustainable evolution of Businesses. With offices in India and United Kingdom, Team Aptapp is an optimal mix of seasoned business and technical professionals boasting diverse experiences from around the Globe

Bubbleye is an innovative AI startup specializing in mobile marketing solutions. With research and development headquarters in Taipei, the company addresses inefficiencies in mobile user acquisition through advanced automation and inferential algorithms. Founded by a diverse team of AI experts and mobile gaming enthusiasts from Italy, Taiwan, the USA, and the UK, Bubbleye leverages its global talent pool to deliver cutting-edge technology to clients, which include leading game publishers from the Americas, Europe, and Asia. The company's recent Series A funding round was supported by Taipei-based Darwin Ventures and notable angel investors, enhancing its growth trajectory. Bubbleye's culture encourages innovation and collaboration, driven by a shared passion for disrupting the mobile marketing landscape and delivering superior performance for its clients.

Breather is an app and a provider of space-as-a-service, with a growing network of private workspaces built for productivity. It enables businesses to access flexible workspace by the hour, day, or month. Every space is designed to be comfortable, private, and productive, with plug-and-play technology that ensures that can get to work as soon as the arrival. Founded by CEO Julien Smith in 2012, the company has grown to include hundreds of locations in 10 major across the globe including New York, San Francisco, Los Angeles, and London.

Kokoon Technology Limited is a digital health company based in London, United Kingdom, specializing in sleep enhancement solutions. Founded in 2013, the company manufactures sleep sensing headphones that incorporate EEG brainwave sensing technology to monitor sleep patterns. These headphones feature active noise cancellation, noise isolation, and white noise capabilities for improved sleep quality. Additionally, Kokoon offers a mobile application that includes an audio relaxation library and sleep analysis tools, utilizing movement and EEG sensors to gain insights into individual sleep behaviors. By combining advances in sensor technology and data science, Kokoon aims to personalize and enhance the sleep experience for users.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Sian's Plan makes healthy eating convenient. They're up early, in bed late and in between it's go go go. Throw a couple of kids into the equation and where is the time for healthy food? All of a sudden it becomes very difficult for you to take care of what matters most to you, keeping yourself and your family healthy. Sian's Plan solves this. ✷Target Market✷ Their target market are young professional/busy mums with one or more school going children. They are technology savvy, using the internet daily and spend on average £100 per weekly shop. Young professionals are a secondary market showing organic growth and They intend to expand into this market once resources allow. ✷Key stats✷ ◇ Average time spent by an active member is 4 min on recipes, 4 min on meal planning and 4 min on grocery list per visit. ◇ 5k members if free beta ◇ Beat Yummly to be awarded "Most innovative digital solution for home cooks globally" in 2012. ✷Business model✷ Primary – Subscriptions: Subscribers pay either £4.99/m and £9.99/m. Secondary – Affiliate commission: Supermarkets pay between £5 and £8 per new purchasing sign up and between 25p and £1 per transaction originating from Sian’s Plan. ✷Team✷ Vincent is the hands on CEO described as 'one of London's hottest culinary entreprenuers' by The Guardian. Sian is the expert who embodies the home cook. Fiona brings vast experience in operations and business development from her managerial position in Deloitte. Glyn Britton (Albion London) advises on marketing, Colin Mitchell (ex-CTO Tesco diets) on tech and Sian Porter (spokeswoman for the British Dietetic Association) on nutrition. ✷Market✷ Currently focused on the UK they are perfectly positioned to scale to the US and Australia where current angels are based. The Mama Market is $2.1 Trillion Strong and growing (Forbes). 19.5 million households in the UK alone engage in some sort of menu planning and with 44% of us shopping online for groceries, sales are expected to be £9.6bn by 2015. ✷Latest member review✷ Hi Sian, thank you guys!! You ve really helped me out, with 2 young boys and little culinary imagination it's [Sian's Plan] amazing! Rose, UK. Rose averages 1.47 visits per day over 30 days, signed up to the yearly £9.99 package and in her own words "I have recommended it to a lot of other mums!".

Gamer Guides is a publisher based in Manchester, UK, specializing in interactive digital strategy guides for video games. The company offers a platform that provides comprehensive game information, walkthroughs, and strategies, catering to both gaming professionals and enthusiasts. Its guides are accessible through an iOS app and the website www.gamerguides.com, allowing users to find reliable and engaging resources for navigating various video games. By centralizing game-related information, Gamer Guides aims to enhance the gaming experience for its users.

Yoyo Wallet Limited is a mobile wallet company based in London, United Kingdom, that facilitates customer transactions for retailers, universities, and corporate locations. Founded in 2013 and originally known as JustYoyo Limited, the company rebranded in April 2015. Yoyo Wallet enables users to make payments using their smartphones, processing over 150,000 monthly in-store transactions by integrating payment and loyalty features through a simple scanning process. Additionally, it offers a marketing platform that enhances digital customer engagement for retailers, allowing them to deliver loyalty programs and rewards tailored to individual buying patterns.

Breather is an app and a provider of space-as-a-service, with a growing network of private workspaces built for productivity. It enables businesses to access flexible workspace by the hour, day, or month. Every space is designed to be comfortable, private, and productive, with plug-and-play technology that ensures that can get to work as soon as the arrival. Founded by CEO Julien Smith in 2012, the company has grown to include hundreds of locations in 10 major across the globe including New York, San Francisco, Los Angeles, and London.

Gamer Guides is a publisher based in Manchester, UK, specializing in interactive digital strategy guides for video games. The company offers a platform that provides comprehensive game information, walkthroughs, and strategies, catering to both gaming professionals and enthusiasts. Its guides are accessible through an iOS app and the website www.gamerguides.com, allowing users to find reliable and engaging resources for navigating various video games. By centralizing game-related information, Gamer Guides aims to enhance the gaming experience for its users.

Gamer Guides is a publisher based in Manchester, UK, specializing in interactive digital strategy guides for video games. The company offers a platform that provides comprehensive game information, walkthroughs, and strategies, catering to both gaming professionals and enthusiasts. Its guides are accessible through an iOS app and the website www.gamerguides.com, allowing users to find reliable and engaging resources for navigating various video games. By centralizing game-related information, Gamer Guides aims to enhance the gaming experience for its users.

WHO WE ARE: Zartis is a digital solutions provider specialised in building cutting-edge software with bespoke development teams. We know good code. And we know nearshore outsourcing, which can be risky when you don't know who to trust. Deep technical experience and hard-earned know-how are our secret ingredients to help you build game-changing software technology while avoiding unnecessary time and budget-wasting engineering shortfalls. Joining the team in one of our global offices in Cork, London, Berlin, Wroclaw, Valencia and Madrid is a big deal. We are a diverse company, with team members drawn from nineteen different nationalities. WHAT WE DO: Zartis partners with firms across e-commerce, financial services, medtech, media, logistics technology, renewable energy, edtech and more. Our engineering hubs in Ireland, Spain, and Poland are full of really clever people delivering business success and digital improvement across application development, software architecture, CI/CD, business intelligence, QA automation and new technology integrations. OUR EXPERTISE: Zartis engineers are uniquely skilled in a broad array of technologies such as JavaScript (Angular, React, Vue), .NET, Java, Python, Scala, Ruby, Go, and cloud-based architectures like AWS, Azure, and Google Cloud. And we manage the whole delivery chain, so there's no added headache.

ShotClip Limited, founded in 2010 and based in Newry, United Kingdom, offers an online video application that allows users to create and share engaging videos. The ShotClip platform provides a user-friendly interface that guides individuals through the video-making process, including planning, recording, and editing. Users can select from a variety of pre-made templates tailored for different events, which help in structuring their videos scene by scene. This collaborative tool allows friends and groups to work together on projects, such as holiday highlights or special occasions. ShotClip operates on a freemium model, offering a free version with limited storage and video quality, while premium accounts provide enhanced features such as HD video export and increased storage options.

Made To Fit Me is a company based in Market Drayton, United Kingdom, that specializes in distributing customized dresses for women, both online and offline. The company addresses the common challenge of finding well-fitting clothing by offering a mass market customization approach that enhances choice and fit. Through an easy-to-follow online measuring process, Made To Fit Me eliminates the trial and error typically associated with shopping for dresses. Each garment is tailored to the individual’s size and taste, using ethically sourced materials, allowing customers to express their unique fashion sense while boosting their confidence.